https://www.ajmc.com/view/fda-approves-one-time-gene-therapy-fidanacogene-elaparvovec-for-hemophilia-b
The FDA has approved fidanacogene elaparvovec-dzkt (Beqvez; Pfizer), a gene therapy administered in a one-time dose, for certain patients with moderate to...
one timegene therapyfidanacogene elaparvovecfdahemophilia